Anja J. Lorch

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications

Response evaluation of neoadjuvant therapy in MIBC: clinical trial-derived evidence to guide practice.

Response evaluation of neoadjuvant therapy in MIBC: clinical trial-derived evidence to guide practice.

Journal: BJU international
Published: August 05, 2026

Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.

Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 29, 2026

Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 29, 2026

Metastatic and recurrent salivary gland carcinoma: clinical characteristics and comprehensive molecular profiling at a tertiary care center.

Metastatic and recurrent salivary gland carcinoma: clinical characteristics and comprehensive molecular profiling at a tertiary care center.

Journal: Journal of cancer research and clinical oncology
Published: September 01, 2025

Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer.

Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer.

Journal: Praxis
Published: May 28, 2025

Improved quality of care for testicular germ cell cancer patients by the implementation of an interdisciplinary testis cancer clinic.

Improved quality of care for testicular germ cell cancer patients by the implementation of an interdisciplinary testis cancer clinic.

Journal: Urologic oncology
Published: April 21, 2025

Thoracic residual germ cell tumor resection after high-dose chemotherapy with autologous stem cell transplantation in relapsed patients.

Thoracic residual germ cell tumor resection after high-dose chemotherapy with autologous stem cell transplantation in relapsed patients.

Journal: World journal of urology
Published: March 26, 2025

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines.

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines.

Journal: European urology
Published: February 14, 2025

PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion.

PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion.

Journal: Frontiers in oncology
Published: May 03, 2024

Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial.

Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial.

Journal: Nature medicine
Published: April 12, 2024

Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31].

Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31].

Journal: European urology
Published: March 16, 2024

Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels.

Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels.

Journal: Urologic oncology
Published: February 27, 2024
Showing 1-12 of 86

Last Updated: 09/26/2026